NCT04671342View on ClinicalTrials.gov

DreamKit Diagnostic Validation

NACompletedINTERVENTIONAL
Enrollment

306

Participants

Timeline

Start Date

January 14, 2021

Primary Completion Date

December 18, 2021

Study Completion Date

December 18, 2021

Conditions
Sleep Apnea, ObstructiveSleep Apnea, Central
Interventions
DEVICE

DreamKit

The DreamKit device is a single-use device intended to aid the diagnosis of sleep-disordered breathing.

Trial Locations (7)

19610

Berks Schuylkill Respiratory Specialists, Wyomissing

21286

Pulmonary and Critical Care Association of Baltimore, Towson

29201

Bogan Sleep Consultants, Columbia

33971

Florida Lung and Sleep Associates, Lehigh Acres

35213

Sleep Disorders Center of Alabama, Birmingham

63143

Clayton Sleep Institute, Maplewood

80918

Delta Waves, Inc., Colorado Springs

All Listed Sponsors
lead

Philips Clinical & Medical Affairs Global

INDUSTRY

NCT04671342 - DreamKit Diagnostic Validation | Biotech Hunter | Biotech Hunter